Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nuvation Bio Inc.
Debiopharm International SA
Essen Biotech
Mayo Clinic
Turning Point Therapeutics, Inc.
Massive Bio, Inc.
City of Hope Medical Center
Hospices Civils de Lyon